中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2013年
15期
902-906
,共5页
李巧珍%陈玉强%颜江华%丁园%王勇军%王生育%叶燕华%许英艺%何蕙香
李巧珍%陳玉彊%顏江華%丁園%王勇軍%王生育%葉燕華%許英藝%何蕙香
리교진%진옥강%안강화%정완%왕용군%왕생육%협연화%허영예%하혜향
树突状细胞%幽门螺杆菌%胃癌
樹突狀細胞%幽門螺桿菌%胃癌
수돌상세포%유문라간균%위암
dendritic cells%Helicobacter pylori%gastric cancer
目的:分析Hp阳性和Hp阴性的胃癌患者外周血单核细胞来源树突状细胞(MODCs)功能的差异性及其临床意义。方法:用尿素14C呼气试验对解放军第一七四医院2011年1月至2012年10月收治的84例胃癌患者进行Hp感染状态鉴定,分别采集Hp阳性和阴性胃癌患者外周血,分离外周血单个核细胞,采用经典方法(rhGM-CSF、rhIL-4联合rhTNF-α)诱导产生DCs,采用流式细胞仪检测DCs表型,采用LDH释放法检测DCs致敏T细胞对胃癌细胞的毒性杀伤作用,采用ELISA方法检测细胞因子IL-12、IFN-γ的分泌水平。结果:两组MoDCs成熟过程形态变化无差异,Hp阳性组MoDCs表面标记分子CD1a、CD80、CD83、CD86和HLA-DR平均表达百分率均高于Hp阴性组,其中CD80、CD83、CD86的表达水平差异有统计学意义,CD1a、HLA-DR差异无统计学意义。Hp阳性组DCs致敏T淋巴细胞对胃癌细胞杀伤率和IL-12、IFN-γ的分泌水平均高于Hp阴性组(P<0.05)。结论:Hp感染状态不影响胃癌患者外周血MoDCs成熟过程形态变化,Hp感染的胃癌患者MoDCs成熟和活化水平更高。
目的:分析Hp暘性和Hp陰性的胃癌患者外週血單覈細胞來源樹突狀細胞(MODCs)功能的差異性及其臨床意義。方法:用尿素14C呼氣試驗對解放軍第一七四醫院2011年1月至2012年10月收治的84例胃癌患者進行Hp感染狀態鑒定,分彆採集Hp暘性和陰性胃癌患者外週血,分離外週血單箇覈細胞,採用經典方法(rhGM-CSF、rhIL-4聯閤rhTNF-α)誘導產生DCs,採用流式細胞儀檢測DCs錶型,採用LDH釋放法檢測DCs緻敏T細胞對胃癌細胞的毒性殺傷作用,採用ELISA方法檢測細胞因子IL-12、IFN-γ的分泌水平。結果:兩組MoDCs成熟過程形態變化無差異,Hp暘性組MoDCs錶麵標記分子CD1a、CD80、CD83、CD86和HLA-DR平均錶達百分率均高于Hp陰性組,其中CD80、CD83、CD86的錶達水平差異有統計學意義,CD1a、HLA-DR差異無統計學意義。Hp暘性組DCs緻敏T淋巴細胞對胃癌細胞殺傷率和IL-12、IFN-γ的分泌水平均高于Hp陰性組(P<0.05)。結論:Hp感染狀態不影響胃癌患者外週血MoDCs成熟過程形態變化,Hp感染的胃癌患者MoDCs成熟和活化水平更高。
목적:분석Hp양성화Hp음성적위암환자외주혈단핵세포래원수돌상세포(MODCs)공능적차이성급기림상의의。방법:용뇨소14C호기시험대해방군제일칠사의원2011년1월지2012년10월수치적84례위암환자진행Hp감염상태감정,분별채집Hp양성화음성위암환자외주혈,분리외주혈단개핵세포,채용경전방법(rhGM-CSF、rhIL-4연합rhTNF-α)유도산생DCs,채용류식세포의검측DCs표형,채용LDH석방법검측DCs치민T세포대위암세포적독성살상작용,채용ELISA방법검측세포인자IL-12、IFN-γ적분비수평。결과:량조MoDCs성숙과정형태변화무차이,Hp양성조MoDCs표면표기분자CD1a、CD80、CD83、CD86화HLA-DR평균표체백분솔균고우Hp음성조,기중CD80、CD83、CD86적표체수평차이유통계학의의,CD1a、HLA-DR차이무통계학의의。Hp양성조DCs치민T림파세포대위암세포살상솔화IL-12、IFN-γ적분비수평균고우Hp음성조(P<0.05)。결론:Hp감염상태불영향위암환자외주혈MoDCs성숙과정형태변화,Hp감염적위암환자MoDCs성숙화활화수평경고。
Objective: This study aimed to compare and analyze the functional differences between peripheral blood mono-cyte-derived dendritic cells (DCs) of Helicobacter pylori-positive and H. pylori-negative patients with gastric cancer. Methods:H. py-lori infection was detected in 84 patients with gastric cancer in our hospital from January 2011 to October 2012 by the 14C-urea breath test. DCs were generated from monocytes isolated by an adherent method from the two groups of patients and cultured in the presence of rhIL-4, rhGM-CSF, and rhTNF-α. Furthermore, the expression of surface marker molecules was determined by fluorescence-activat-ed cell sorting analysis. The cytotoxicity of DCs pulsed T cells against gastric carcinoma cell was assessed by the lactate dehydroge-nase-releasing assay. The secretion of IL-12 and IFN-γin the supernatant was determined by enzyme-linked immunosorbent assay. Re-sults:No difference was observed in the morphological change of the maturation process. The mean expression of CD1a, CD80, CD83, CD86, and HLA-DR molecules in DCs of H. pylori-infected patients was higher than that in DCs of H. pylori-negative group, and the differences were statistically significant except for CD1a and HLA-DR. The cytotoxicity activities, IL-12 release, and IFN-γrelease in the H. pylori-positive group were significantly higher than those in the H. pylori-negative group (P<0.05). Conclusion:H. pylori infec-tion has no effect on the morphological change of the maturation process of monocyte-derived DCs. These data clearly demonstrate that monocyte-derived DCs of H. pylori-infected patients with gastric cancer can induce stronger maturation and activation than those of H. pylori-negative patients.